Zobrazeno 1 - 10 of 12 pro vyhledávání: '"T. W. Littlejohn"'
2
Efficacy and safety of aliskiren and amlodipine combination therapy in patients with hypertension: a randomized, double-blind, multifactorial study
Autor: J Zhang, T W Littlejohn, Deborah L. Keefe, H Hsu, S W Jones
Publikováno v: Journal of human hypertension. 27(5)
Most patients with hypertension need more than one drug to achieve blood pressure (BP) control. This randomized, double-blind, multifactorial study evaluated whether combinations of aliskiren and amlodipine provided superior BP reductions to componen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c73600a0697557893ba13cdf657d852
https://pubmed.ncbi.nlm.nih.gov/23076450
Zobrazit plný text záznamu
3
Effectiveness of a single topical application of 10|x% trolamine salicylate cream in the symptomatic treatment of osteoarthritis
Autor: D Q, Rothacker, I, Lee, T W, Littlejohn
Publikováno v: Journal of clinical rheumatology : practical reports on rheumaticmusculoskeletal diseases. 4(1)
This study was designed to evaluate the effectiveness in relief of pain and rigidity of a 10|X% trolamine salicylate cream compared with a placebo cream identical in smell and appearance, for subjects with osteoarthritis in their hands. This was a on
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::84da553c650042c5206813dc4213681a
https://pubmed.ncbi.nlm.nih.gov/19078236
Zobrazit plný text záznamu
4
The dipeptidyl peptidase-4 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus
Autor: T. W. Littlejohn, G. Garcia-Soria, Sherwyn Schwartz, G. M. Argoud, X. Li, H.-P. Guler, J. M. Cherrington, Craig A. Bennett, G. Gonzalez-Galvez, A. M. O’Farrell, M. Gerstman
Publikováno v: Diabetes, obesitymetabolism. 10(4)
Aim To determine the efficacy and tolerability of PHX1149, a novel dipeptidyl peptidase-4 (DPP4) inhibitor, in patients with type 2 diabetes. Methods This is a multicentre, randomized, double-blind, placebo-controlled, 4-week study in patients with t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b1b38e6b8cfb958ff140aa62405ed0
https://pubmed.ncbi.nlm.nih.gov/18333888
Zobrazit plný text záznamu
6
Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group
Autor: K J, Tack, T W, Littlejohn, G, Mailloux, M M, Wolf, C H, Keyserling
Publikováno v: Clinical therapeutics. 20(2)
Because of increasing resistance to older antimicrobial agents, newer drugs need to be evaluated for the treatment of skin and skin-structure infections (SSSIs). This double-masked, randomized, comparative, multicenter study enrolled patients aged 13
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::43fa8678d625ae4165d3a1b739792eba
https://pubmed.ncbi.nlm.nih.gov/9589816
Zobrazit plný text záznamu
7
Oral sumatriptan in the treatment of recurrent headache
Autor: R K Cady, T W Littlejohn rd, J Rubino, D Crummett
Publikováno v: Archives of family medicine. 3(9)
Background Sumatriptan is effective for the treatment of acute migraine. However, headache may recur in about 30% of patients within 24 hours of successful treatment. Objective To evaluate the efficacy of oral sumatriptan, 100 mg, in the treatment of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cbcf447f1c4ecffb4e0c310cec3726d
https://pubmed.ncbi.nlm.nih.gov/7987510
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje